Journals / Harran Üniversitesi Tıp Fakültesi Dergisi / 2008 / Cilt: 5 - Sayı: 1

Economic Analysis Of Hospital Acquired Infections: A Case-Control Study

Hastane İnfeksiyonlarında Maliyet Analizi: Olgu-Kontrol Çalışması

Pages
15–21
Publication Date
2008-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean total length of stay was 19.1 and 10.0 days for infected patients with uninfected controls, respectively p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Hospıtal acquired infections HAI constitute an important with morbidity, and high mortality, prolongation of hospital stay, and increased costs of direct patient care.
📊
Key Findings & Data:Material-Methods: Data collected from 102 individuals with hospıtal acquired infections and 125 controls without hospıtal acquired infections were recorded by using a computer program SPSS 10.0 .
💡
Conclusion & Impact:The mean total length of stay was 19.1 and 10.0 days for infected patients with uninfected controls, respectively p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hastane Infeksiyonları · Maliyet · Kalış Süresi

Abstract

Introduction: Hospıtal acquired infections HAI constitute an important with morbidity, and high mortality, prolongation of hospital stay, and increased costs of direct patient care. Aim: This study was conducted in Pamukkale University Hospital in order to determine in cost of hospıtal acquired infections and length of hospitalization by matching infected patients with uninfected controls. Material-Methods: Data collected from 102 individuals with hospıtal acquired infections and 125 controls without hospıtal acquired infections were recorded by using a computer program SPSS 10.0 . Results: Urinary tract infections, pneumoniae and surgical wound infections were the most common hospıtal acquired infections. The mean total length of stay was 19.1 and 10.0 days for infected patients with uninfected controls, respectively p

Özet

Giriş: Hastane İnfeksiyonları morbidite ve yüksek mortalite, hastanede kalış süresinin uzaması ve artmış hasta bakım maliyeti ile önem oluşturmaktadır. Amaç: Bu çalışma Pamukkale Üniversitesi Hastanesi’nde infekte olmayan kontrol grubu ile infekte hastaların karşılaştırılması ile hastane infeksiyonlarının maliyetini ve hastanede kalış süresini tespit etmek için yapıldı. Materyal-Metod: Çalışmada hastane infeksiyonu olan 102 ve hastane infeksiyonu olmayan 125 hastadan toplanan veriler bilgisayar programına kaydedildi SPSS 10.0 . Sonuç: Üriner sistem infeksiyonları, pnömoni ve cerrahi alan infeksiyonları en yaygın hastane infeksiyonlarıydı. Toplam yatış süresi infekte olan ve olmayan kontrollerde sırasıyla 19.1 ve 10.0 gündü p

🔖

Cite This Article

GÜRSOY, B. (2008). Economic Analysis Of Hospital Acquired Infections: A Case-Control Study. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 5 - Sayı: 1, 15–21. https://ajindex.com/articles/22638

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost and prevention. Epidemiol 1996;17:552-57
  2. Control Hosp Plowmann R, Graves N, Griffin MAS, et al. The rate and cost of hospital-acquired infections occuring in patients admitted to selected specialities of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209 Yalcin AN. Socioeconomic Burden of Nosocomial Infections. Indian J Med Sciences 2003;57: 450-456 Yalçın AN. İnfeksiyon kontrolünde maliyet analizi; Hastane İnfeksiyonları. Editörler: Doğanay M, Ünal S. Birinci Baskı. Ankara. Bilimsel Tıp Yayınevi 2003; 125-134
  3. Garner JS, Jarwis WR, Emori TG, et al.: CDC infections, 1988. Am J Infect Control nosocomial Haley RW, Morgan WM, Culver DH, et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985;13: 97-108
  4. Keresedizle T, Mangay MA, Galacas A: Nosocomial infections-what WHO is doing? J Hosp Infect 1984; 5:7-12
  5. Yalcin AN, Hayran M, Unal S. Economic Analysis of Nosocomial Infections in a Turkish University Hospital. J Chemother 1997;9: 411– 14 French GL, Cheng AFB. Measurement of the costs of the hospital infection by prevelance surveys. J Hosp Infect, 1991;18: 65-72
  6. Westwood JCN, Legrace S, Mitchell MA. Hospital Acquired İnfection: Present and future impact and need for positive action. Can Med Assoc J 1974;110:769- 74 Rosenthal VD, Guzman SN, Orellano PW. Nosocomial infections in medical- surgical intensive care units in Argentina: Attributable mortality and length of stay. Am J Infect Control 2003;31: 291-95
  7. Diaz Molina C, Garcia Martin M, Buena Cavallinas A, et al. The estimation of the cost nosocomial infection is an intensive care unit. Medicina Clinica 1993; 100: 329-32
  8. Orrett F A, Brooks P J, Richardson EG. Nosocomial ınfections in a rural regional hospital in a developing country: Infections rates by site, service, cost and infection control practice. Infect Control Hosp Epidemiol 1998;19:136-40
  9. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges infections in a neonatal intensive care unit. J Hosp Infect. 2001;47: 223- 29 Leroyer A, Bedu A, Lombrail P, et al. Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. J Hosp Infect. 1997;35: 37-45
  10. Astagneau P, Fleury L, Leroy S, et al. Cost of antimicrobial treatment for nosocomia